Giedrius Zunda

Technik-/Wissenschafts-/F&E-Leiter bei ALVOTECH

Consumer Services

Health Technology

Transportation

Profil

Giedrius Zunda is currently working as the Chief Technology Officer at Alvotech.
Previously, he worked as the Chief Executive Officer at Northway Biotech, Inc. He has a graduate degree from Vilniaus Gedimino Technikos Universitetas and an MBA from Baltic Management Institute.

Aktive Positionen von Giedrius Zunda

Unternehmen	Position	Beginn
ALVOTECH	Technik-/Wissenschafts-/F&E-Leiter	01.01.2023

Alle aktiven Positionen von Giedrius Zunda

Ehemalige bekannte Positionen von Giedrius Zunda

Unternehmen	Position	Ende
Northway Biotech, Inc. Northway Biotech, Inc. Marine ShippingTransportation Northway Biotech, Inc. is a contract development and manufacturing organization (CDMO) specializing in protein-based biologics, gene therapies, plasmid DNA, and viral vectors. The private company is based in Waltham, MA. The company provides end-to-end services including cell line development (mammalian and microbial), process development, analytical methods, formulation development, viral clearance studies, cGMP manufacturing (cell banking, drug substance, and drug product), and aseptic fill-finish. Its manufacturing capabilities feature scalable mammalian cell culture and microbial fermentation using bioreactors up to 4000 L and 3000 L, respectively, with strict separation of microbial and mammalian processes. Northway Biotech ensures regulatory compliance with FDA and EMA standards, offering quality assurance, quality control, and regulatory affairs support for product safety and successful submissions. The company participates in EU-funded research projects focused on biosimilar monoclonal antibodies and innovative microbial biosynthesis technologies, integrating molecular biology, genetic engineering, and biotechnology to deliver scalable bioprocesses. The CEO of the company is Vladas Algirdas Bumelis.	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von Giedrius Zunda im Detail an

Ausbildung von Giedrius Zunda

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Giedrius Zunda im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Baltic Management Institute Baltic Management Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vilniaus Gedimino Technikos Universitetas Vilniaus Gedimino Technikos Universitetas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alvotech Alvotech BiotechnologyHealth Technology Develops biologic medicines	Health Technology
Northway Biotech, Inc. Northway Biotech, Inc. Marine ShippingTransportation Northway Biotech, Inc. is a contract development and manufacturing organization (CDMO) specializing in protein-based biologics, gene therapies, plasmid DNA, and viral vectors. The private company is based in Waltham, MA. The company provides end-to-end services including cell line development (mammalian and microbial), process development, analytical methods, formulation development, viral clearance studies, cGMP manufacturing (cell banking, drug substance, and drug product), and aseptic fill-finish. Its manufacturing capabilities feature scalable mammalian cell culture and microbial fermentation using bioreactors up to 4000 L and 3000 L, respectively, with strict separation of microbial and mammalian processes. Northway Biotech ensures regulatory compliance with FDA and EMA standards, offering quality assurance, quality control, and regulatory affairs support for product safety and successful submissions. The company participates in EU-funded research projects focused on biosimilar monoclonal antibodies and innovative microbial biosynthesis technologies, integrating molecular biology, genetic engineering, and biotechnology to deliver scalable bioprocesses. The CEO of the company is Vladas Algirdas Bumelis.	Transportation